FDA Avandia Hearing Update – Committee Votes to Keep Avandia on the Market…
The FDA advisory panel on Avandia voted in favor of keeping Avandia (rosiglitizone) on the market the vote breaks down as…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
avandia
FDA Avandia Hearing Update – Committee Votes Increased Risk of CV events,…
After almost two days of rigorous debate, the time for the FDA vote on the fate of Avandia is upon us.
The 33 member FDA advisory…
Senate Finance Committee Staff Report On GlaxoSmithKline and The Diabetes…
Today the New York Times published some of the findings of a report conducted by the Senate Finance Committee Staff on the…
Plaintiff Law Firm Announces Results of Avandia Clinical Trials…
If two recent cases highlighting plaintiff’s lawyer’s abuse of medical experts was not enough, last week the Sanders Firm…